Is Pharma Building the Right Facilities for Future Biologics?

As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require

• By

• Miriam Monge

• November 9, 2026

• 5 min

• The Medicine Maker